In 2019 Incyte’s drug Jakafi (ruxolitinib) became the first medication FDA approved for the treatment of steroid-refractory acute GVHD in adult and pediatric patients 12 years and older. Each year in the US about half of the patients who develop acute GVHD do not respond adequately to steroids, which is why it is such an […]
Post Type Archives: Blog
Hot off the Press: FDA Approves New Treatment for Heart Failure with Reduced Ejection Fraction
Hot off the Press: FDA Approves New Treatment for Heart Failure with Reduced Ejection Fraction On May 5, 2020 after receiving a Priority Review designation, the FDA announced a new indication for Farxiga (dapagliflozin) for adults of whom have heart failure with reduced ejection fraction to reduce the risk of cardiovascular death and hospitalizations for […]
Researchers provide new insights into hearing loss
Researchers provide new insights into hearing loss Between one-quarter and one-third of individuals older than 65 experience age related hearing loss. Today, researchers are gaining new perspectives into risk factors that may help prevent or delay the onset of impaired hearing. Some studies in recent years have investigated the possibility of a connection between […]
How the Elderly Can Manage the Mental Health Impacts of the COVID-19 Pandemic
Due to the strict precautions many geriatric adults are being recommended to take by the CDC, for many patients this is having a severe impact on their overall mental health. We need to ensure that the mental health needs of the elderly are met to prevent further distress, all while doing so from a safe […]
Web Design by Venbit
